reference/1202184

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1202184

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	2073
issn	1499-2752 0315-162X
issueIdentifier	11
pageRange	2068-2073
publicationName	The Journal of Rheumatology
startingPage	2068
bibliographicCitation	Birolo C, Zannin ME, Arsenyeva S, Cimaz R, Miserocchi E, Dubko M, Deslandre CJ, Falcini F, Alessio M, La Torre F, Denisova E, Martini G, Nikishina I, Zulian F. Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis. J Rheumatol. 2016 Nov;43(11):2068–73. doi: 10.3899/jrheum.151389. PMID: 27633826.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b8e830eaa006947289a5043429c56d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2479-3485 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e158bc38d059c816baa4685c2003d0f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2170d8576f3969c12a10165322c869f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_300f9620a845e202c0a3fb598864731d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3260-4226 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0ed8ea3e5151c9f63263ed559e3d206 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_596f8296fe3e9a684f2eb3d87aacadaf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61a45be118b5e76ff41136a4069e1300 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cc5601437268dedfc14c2e466f2fa29 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5235-2900 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1842-0348 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bbe876ebd7805592e11944be4ff071cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9803-0221 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7275f639b5c8cc26878880af811f728f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_482c00848b133e03899b295c5333991a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04d7d63495fa22648c69c6de2bd2553d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3801-8903 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1837abdea7ecb16f3ca1379187255a82 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff14e1c037367511b0da5b52dae37f18
date	2016-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/27633826 https://doi.org/10.3899/jrheum.151389
isPartOf	https://portal.issn.org/resource/ISSN/0315-162X https://portal.issn.org/resource/ISSN/1499-2752 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5243
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis
discusses	http://id.nlm.nih.gov/mesh/M0442852 http://id.nlm.nih.gov/mesh/M0027742 http://id.nlm.nih.gov/mesh/M0011171
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014605Q000188 http://id.nlm.nih.gov/mesh/D018501Q000627 http://id.nlm.nih.gov/mesh/D000069594Q000627 http://id.nlm.nih.gov/mesh/D007166Q000627 http://id.nlm.nih.gov/mesh/D001171Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D002648 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D002675 http://id.nlm.nih.gov/mesh/D019233 http://id.nlm.nih.gov/mesh/D055815
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8096 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9573 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6965 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6968 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ab9bc7ce433266ca5b4543e538aeed73

Total number of triples: 61.